JPM vs Greenhill vs Ducera

Interested in these 3 for their NY offices and want to go to the buy-side after my analyst stint; obviously JPM has top 3 BB prestige (not GS/MS tho) but has group placement risk and a lower return offer rate, Greenhill isn't what it once was but still has solid MM/UMM/MF PE exits, and Ducera pays its analysts $200k+ but has the worst hours and exits generally limited to credit roles. Thoughts?

 
[Comment removed by mod team]
 

not OP, but at least in the CHI office all greenhill analysts exit to MF/UMM, exits are still top

 

I think you idea that of Ducera exits being limited is partially due to selection bais. In order to have a shot with them you really need to be passionate about RX and I think that just leads to more moving to credit buyside. I know they had a couple people that exited to HIG and 1 to EQT in the last couple years, which isn't bad given class size. Anyways, if you just want to do M&A, I would say JPM > Greenhill >= Ducera(mix M&A and RX) not sure how much longer Greenhill over Ducera will last, since one is struggle and one is growing.

 

Are these things still true? You can't even find Greenhill on league tables anymore while they used to be top 15 ten years ago.

Yes to pay and placements. League tables is not totally indicative of buyside interest. There is a lot of prestige/legacy/preference factor. There was another thread awhile ago that compiled buyside placement from BB's. Credit Suisse was the strongest out of mid-tier BB's even though their deal volume has fallen behind over the past few years.

 
Most Helpful

If you let WSO convince you to take Greenhill over JPM, you shouldn't have a JPM offer. Can't think of a single buy-side firm that hires from Greenhill and not JPM or in preference to them, whereas in any exit outside finance, JPM >>>>> Greenhill.

 

Doesn't JP have the same prestige factor as well? If M&A deal flow is dead doesn't that mean you're just pitching all the time and MDs are stressed struggling to bring in fees so they take it out on analysts?

 

JPM definitely has the same prestige factor and a much, much stronger brand globally, but for the purpose of OP's question we cannot ignore group placement risk. If M&A deal flow does indeed "die", how will the MD's react? And how will that affect the analyst experience? It's a hypothetical question that nobody really knows.  It is a good thought to ponder on though.

 

Bro… jpm over both of those and its not even a question.

 

All are sweaty so just take Jp for prestige and brand recognition if you care about that, or one of the others for the comp

 

If you’re interested in buyout roles or M&A type stuff then JPM hands down. If you know you’re interested in distressed or special situations then Ducera would be best.

 

Interested to hear what people’s thoughts are given 2022 An1 bonus numbers are widely available now. GHL bonuses averaged $85k and JPM averaged $40-45k. Haven’t seen many Ducera numbers.

 

Hard to say what an average exit is when JPM analyst classes are so large

 

Ipsum aliquam est dolor ab eum exercitationem. Consequuntur porro rem pariatur saepe laborum adipisci voluptatem. Voluptatibus quo maiores dolorum non quaerat ut qui qui.

Omnis in non libero. Eaque est itaque veritatis praesentium aliquid tenetur. Vitae ut corporis aspernatur et quaerat ad.

A porro deleniti porro quo dicta aut. Nemo dolorem quia voluptas qui. Et facilis corporis officia quaerat quidem. Et assumenda illo quidem voluptates ipsa nulla.

Sunt in magnam vel sed. Libero maxime maxime laudantium dolorem recusandae minima molestias laborum. Expedita quia dolore voluptatum et qui et.

 

Omnis sunt expedita laudantium qui a. Eius dolorum quaerat autem maxime. Reiciendis culpa alias sit nihil ea distinctio nesciunt. Facilis neque assumenda sunt tenetur odit.

Sunt possimus quia aliquid et quo. Rerum suscipit quod delectus tempora. Consequatur assumenda sint nihil sit quas magni id dignissimos. Nihil iure id illum amet.

Et aut suscipit magnam molestias earum sed. Optio doloremque sit ratione eum qui nemo.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
kanon's picture
kanon
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”